Cytomegalovirus infection is a risk factor for TB disease in infants

Cytomegalovirus infection is a risk factor for TB disease in infants

Immune activation is associated with increased risk of tuberculosis (TB) disease in infants. We performed a case control analysis to identify drivers of immune activation and disease risk. Among 49 infants who developed TB disease over the first two years of life, and 129 matched controls who remain...

Full description

Bibliographic Details
Main Authors:	Müller, J, Tanner, R, Matsumiya, M, Snowden, MA, Landry, B, Satti, I, Harris, SA, O'Shea, MK, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Thomas, Z-R, Stylianou, E, Naranbhai, V, Mbandi, SK, Hatherill, M, Hussey, G, Mahomed, H, Tameris, M, McClain, JB, Hanekom, WA, Evans, TG, Scriba, TJ, McShane, H
Format:	Journal article
Language:	English
Published:	American Society for Clinical Investigation 2019

Similar Items

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
by: Tameris, MD, et al.
Published: (2013)

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.
by: Fletcher, H, et al.
Published: (2016)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Fletcher, H, et al.
Published: (2016)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial
by: Tameris, MD, et al.
Published: (2013)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response
by: Matsumiya, M, et al.
Published: (2014)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
by: Matsumiya, M, et al.
Published: (2014)

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
by: Andrews, J, et al.
Published: (2017)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Helen A. Fletcher, et al.
Published: (2016-04-01)

Correction: Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Helen A. Fletcher, et al.
Published: (2016-05-01)

Publishing vaccine trial results – Does there have to be a delay?
by: McShane, H, et al.
Published: (2014)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
by: Harris, SA, et al.
Published: (2014)

The role of clinical symptoms in the diagnosis of intrathoracic tuberculosis in young children
by: Mcshane, H, et al.
Published: (2015)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.
by: Tameris, M, et al.
Published: (2013)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
by: Tameris, M, et al.
Published: (2013)

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals.
by: Schmidt, B, et al.
Published: (2017)

Risk of disease after isoniazid preventive therapy for mycobacterium tuberculosis exposure in young HIV uninfected children
by: Mcshane, H, et al.
Published: (2015)

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination
by: Bunyasi, E, et al.
Published: (2017)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
by: Tameris, M, et al.
Published: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
by: Tameris, M, et al.
Published: (2014)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
by: Hawkridge, T, et al.
Published: (2008)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
by: Matsumiya, M, et al.
Published: (2014)

Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis.
by: Mark Hatherill, et al.
Published: (2006-12-01)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
by: Michele Tameris, et al.
Published: (2014-01-01)

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
by: Dintwe, O, et al.
Published: (2013)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
by: Tanner, R, et al.
Published: (2017)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
by: Stylianou, E, et al.
Published: (2015)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
by: Satti, I, et al.
Published: (2022)

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.
by: Scriba, T, et al.
Published: (2010)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
by: Mcshane, H, et al.
Published: (2016)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
by: Tanner, R, et al.
Published: (2020)

Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South Africa
by: Mark Hatherill, et al.
Published: (2010-04-01)

Elevated IgG responses in infants are associated with reduced prevalence of Mycobacterium tuberculosis infection
by: Logan, E, et al.
Published: (2018)

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed Bacille Calmette-Guerin (BCG) for infants of HIV infected mothers: A phase 2 randomized controlled trial.
by: Nemes, E, et al.
Published: (2017)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.
by: Rustomjee, R, et al.
Published: (2013)

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
by: Scriba, T, et al.
Published: (2011)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents
by: Rustomjee, R, et al.
Published: (2013)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
by: Marsay, L, et al.
Published: (2013)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
by: Pinpathomrat, N, et al.
Published: (2021)

Likes, comments, and shares of marine organism imagery on Facebook
by: Craig R. McClain
Published: (2019-04-01)

Practices and promises of Facebook for science outreach: Becoming a "Nerd of Trust".
by: Craig R McClain
Published: (2017-06-01)